Molecule intelOpportunity: StrongEssential

Acetylsalicylic Acid

26 brands · 11 companies · product forms

ATC: A01AD05, B01AC06, N02BA01 2 DRAP alerts

Opportunity snapshot

Launch attractiveness
63
Market saturation
31
Price room
100
Regulatory risk
70
26
brands
11
companies
Rs 84.84
median price
36
price points
64.28x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 19%

Price room

Across observed sources and strengths
CheapestRs 31.2
MedianRs 84.84
Most expensiveRs 2,005.44
Spread64.28×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 64.28x across 36 trusted points (Rs 31.2-2005.44). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory alerts

Recall exposurelatest 2025-12-16
Drug Product Recall: Disprin Tablets (Batch # 2BN1080) by M/s. Reckitt Benckiser Pakistan
119. Recall Alert (Class-II) – Drug Products (Human) Substandard -DTL Punjab

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(69) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

11 canonical companies and 26 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 64.28x across 36 trusted points (Rs 31.2-2005.44). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

2 DRAP alert(s), latest 2025-12-16 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.